Guest guest Posted January 11, 2011 Report Share Posted January 11, 2011 Increased offer for NHS patients infected with hepatitis C 'disappointing' The Guardian People who contracted hepatitis C as a result of contaminated blood transfusions decades ago are to be given substantially increased compensation, ... See all stories on this topic » The Guardian Bristol-Myers, Pharmasset plan hepatitis C study Bloomberg By AP NEW YORK (AP) — Bristol-Myers Squibb Co. and Pharmasset Inc. said Monday they will run a clinical trial testing the combination of two hepatitis C ... See all stories on this topic » Peregrine Begins Phase II Trial Of Bavituximab In Chronic Hepatitis C RTT News .... Inc. (PPHM: News ) said it has initiated a mid-stage clinical trial in patients with previously untreated genotype-1 hepatitis C virus (HCV) infection. .... See all stories on this topic » Peregrine initiates Phase II hepatitis C virus trial Trading Markets (press release) .... a biopharmaceutical company, has initiated a randomized Phase II clinical trial in patients with previously untreated genotype-1 hepatitis C virus, ... See all stories on this topic » Boceprevir, Merck's Investigational Oral Hepatitis C Protease Inhibitor ... Medical News Today (press release) Merck, known as MSD outside the United States and Canada, announced that regulatory applications for boceprevir, Merck's investigational oral hepatitis C .... See all stories on this topic » Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 11, 2011 Report Share Posted January 11, 2011 Increased offer for NHS patients infected with hepatitis C 'disappointing' The Guardian People who contracted hepatitis C as a result of contaminated blood transfusions decades ago are to be given substantially increased compensation, ... See all stories on this topic » The Guardian Bristol-Myers, Pharmasset plan hepatitis C study Bloomberg By AP NEW YORK (AP) — Bristol-Myers Squibb Co. and Pharmasset Inc. said Monday they will run a clinical trial testing the combination of two hepatitis C ... See all stories on this topic » Peregrine Begins Phase II Trial Of Bavituximab In Chronic Hepatitis C RTT News .... Inc. (PPHM: News ) said it has initiated a mid-stage clinical trial in patients with previously untreated genotype-1 hepatitis C virus (HCV) infection. .... See all stories on this topic » Peregrine initiates Phase II hepatitis C virus trial Trading Markets (press release) .... a biopharmaceutical company, has initiated a randomized Phase II clinical trial in patients with previously untreated genotype-1 hepatitis C virus, ... See all stories on this topic » Boceprevir, Merck's Investigational Oral Hepatitis C Protease Inhibitor ... Medical News Today (press release) Merck, known as MSD outside the United States and Canada, announced that regulatory applications for boceprevir, Merck's investigational oral hepatitis C .... See all stories on this topic » Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.